Abstract | BACKGROUND: DESIGN: In this review, we provide a brief overview of the pathophysiology of axSpA. In addition, we performed a quantitative text analysis of reviews on the pathogenesis of axSpA published in the last 10 years to establish the current consensus in various fields of research into the pathogenesis of axSpA. RESULTS: There appears to be broad consensus on genetic risk factors and the involvement of the immune system in the initiation phase of the disease although little consensus was found on which specific immune cells drive disease. Moreover, despite relatively little data available, alterations in the microbiome are commonly thought to be involved in disease. Abnormal bone formation is the most prominent pathogenic factor thought to be involved in disease progression. CONCLUSION: So, although the pathophysiology of axSpA remains incompletely understood, the progress in recent years in several fields of research in axSpA including genetics, diagnosis, imaging and therapeutics, hold great promise for the future.
|
Authors | Anoek de Koning, Jan W Schoones, Desiree van der Heijde, Floris A van Gaalen |
Journal | European journal of clinical investigation
(Eur J Clin Invest)
Vol. 48
Issue 5
Pg. e12913
(May 2018)
ISSN: 1365-2362 [Electronic] England |
PMID | 29460306
(Publication Type: Journal Article, Review)
|
Copyright | © 2018 Stichting European Society for Clinical Investigation Journal Foundation. |
Chemical References |
|
Topics |
- Arthritis
(etiology, therapy)
- Genetic Predisposition to Disease
- HLA-B27 Antigen
(physiology)
- Humans
- Osteogenesis
(physiology)
- Risk Factors
- Sacroiliac Joint
(pathology)
- Spondylarthritis
(etiology, therapy)
- Spondylitis, Ankylosing
(etiology, therapy)
- Stress, Mechanical
|